HIV Treatment: ART, PrEP, PEP, and Comprehensive Care

Modern HIV Management

Antiretroviral Therapy (ART)

  • Combination of ≥2 drug classes (e.g., 2 NRTIs + an integrase inhibitor).
  • Goal: viral suppression (<50 copies/mL) → immune recovery, zero transmission risk (U=U).
  • Lifelong, daily adherence is essential.

Prevention

  • PrEP (Pre-Exposure Prophylaxis): Daily TDF/FTC or TAF/FTC (or long-acting injectable cabotegravir) for HIV-negative high-risk individuals. >99% effective with adherence.
  • PEP (Post-Exposure Prophylaxis): 28-day ART course started ≤72 hours after exposure. High efficacy if started early.

Adjunctive Care

  • Prophylaxis/treatment of opportunistic infections (PCP, toxoplasmosis, MAC, fungal).
  • Vaccinations (pneumococcal, hepatitis A/B, HPV, COVID).
  • Cardiovascular, renal, and bone monitoring.
  • Mental health, substance use, and social support services.

Key Message

With ART, HIV is a manageable chronic condition. Regular care = near-normal lifespan.

HIV & AIDS - Related Articles